Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $23.00M | 41,889,142 | 12.20% | 14.47% | Net Buying | |||
| KALA | KALA BIO INC | $9.94M | 6,452,398 | 6.83% | 93.17% | Net Selling | Net Selling | ||
| ACXP | ACURX PHARMACEUTICALS INC | $7.21M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| ATYR | ATYR PHARMA INC | $68.98M | 89,004,436 | 74.54% | 17.28% | Net Buying | |||
| MRSN | MERSANA THERAPEUTICS INC | $41.32M | 4,990,692 | 30.77% | 69.23% | Net Selling | Net Selling | ||
| GOVX | GEOVAX LABS INC | $14.71M | 25,359,593 | 0.21% | 99.79% | Net Buying | Net Buying | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $81.60M | 17,661,698 | 29.13% | 25.91% | ||||
| FGEN | FIBROGEN INC | $47.43M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Selling | ||
| NRXP | NRX PHARMACEUTICALS INC | $64.44M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| SGMO | SANGAMO THERAPEUTICS INC | $206.07M | 301,709,485 | 16.98% | 10.66% | Net Selling | Net Selling | ||
| GRI | GRI BIO INC | $4.80M | 2,515,305 | 0.71% | 99.29% | ||||
| FEMY | FEMASYS INC | $17.16M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| PSTV | PLUS THERAPEUTICS INC | $72.46M | 99,264,526 | 0.38% | 23.86% | Net Buying | Net Buying | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.83M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.29M | 23,858,301 | 10.74% | 60.23% | ||||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.19M | 1,919,441 | 4.26% | 95.74% | Net Buying | |||
| LSTA | LISATA THERAPEUTICS INC | $21.67M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| MDCX | MEDICUS PHARMA LTD | $45.25M | 17,816,266 | 11.79% | 55.54% | Net Buying | Net Buying | ||
| MTVA | METAVIA INC | $24.92M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| CING | CINGULATE INC | $22.62M | 5,412,523 | 3.75% | 96.25% | ||||
| MBRX | MOLECULIN BIOTECH INC | $13.99M | 30,286,168 | 1.43% | 20.90% | Net Buying | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.36M | 1,205,402 | 0.38% | 99.62% | Net Selling | |||
| SLN | SILENCE THERAPEUTICS PLC | $235.93M | 141,701,848 | 13.95% | 0.09% | ||||
| CRDL | CARDIOL THERAPEUTICS INC | $88.46M | 82,674,725 | 7.82% | 0.00% | ||||
| MYO | MYOMO INC | $35.95M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| JSPR | JASPER THERAPEUTICS INC | $40.47M | 16,253,332 | 20.42% | 79.58% | Net Buying | Net Buying | ||
| INTS | INTENSITY THERAPEUTICS INC | $13.18M | 47,057,727 | 4.20% | 4.44% | Net Buying | |||
| PASG | PASSAGE BIO INC | $25.27M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Buying | ||
| NOTE | FISCALNOTE HOLDINGS INC | $74.05M | 14,349,995 | 31.65% | 68.35% | Net Selling | Net Selling | ||
| IMUX | IMMUNIC INC | $93.71M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| PMN | PROMIS NEUROSCIENCES INC | $25.90M | 51,806,497 | 16.36% | 49.79% | Net Buying | |||
| TIL | INSTIL BIO INC | $122.19M | 6,750,716 | 5.76% | 94.24% | Net Buying | Net Buying | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $12.05M | 1,261,290 | 0.39% | 99.61% | Net Selling | |||
| ACET | ADICET BIO INC | $69.06M | 82,709,625 | 62.39% | 19.44% | Net Selling | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $14.63M | 2,611,788 | 0.26% | 99.74% | ||||
| ANVS | ANNOVIS BIO INC | $43.26M | 19,486,231 | 9.30% | 15.63% | Net Buying | Net Buying | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $295.10M | 221,881,029 | 70.14% | 29.86% | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.